Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Pulmonary Hypertension, November 2025 Free Subscription Abstracts Retrieve all available abstracts of the following 149 articles: HTML format

Single Articles

1. XING Y, Liu C, Zhang C, Zhou D, et al
   Antibiotic-driven and microbiota-targeted therapy for advanced management of pulmonary hypertension.
   Respir Res. 2025;26:303.
   PubMed    
   Abstract available
   
   

2. WHITE RD, Demirer M, Sebro RA, Cortopassi IO, et al
   Artificial intelligence improves detection and classification of pulmonary venous hypertension related to left ventricular diastolic dysfunction by chest radiography.
   Sci Rep. 2025;15:38181.
   PubMed    
   Abstract available
   
   

3. BOUCLY A, Beauvais A, Lacoste-Palasset T, Jevnikar M, et al
   Evolving paradigms in pulmonary hypertension: Highlights of the 6(th) French Pulmonary Hypertension Network Meeting.
   Respir Med Res. 2025;88:101215.
   PubMed    
   
   
   

4. MOON GS, Scheel PJ 3rd, Montovano M, Kaushik M, et al
   A Novel Computational Pipeline for Acquiring Pressure-Volume Hemodynamics of the Right Ventricle in Pulmonary Hypertension.
   JACC Heart Fail. 2025 Oct 31:102753. doi: 10.1016/j.jchf.2025.102753.
   PubMed    
   Abstract available
   
   

5. ALTURAIF N, Lin E, Sundararaghavan A, Mercurio V, et al
   Predicting outcomes in patients with pulmonary hypertension using right ventricular global longitudinal strain versus tricuspid annular plane systolic excursion (TAPSE) and fractional area change: a retrospective analysis.
   J Cardiovasc Imaging. 2025;33:15.
   PubMed    
   Abstract available
   
   

6. YANG Y, Yu H, Xiang Q, Wu J, et al
   Assessment of a Grad-CAM interpretable deep learning model for HAPE diagnosis: performance and pitfalls in severity stratification from chest radiographs.
   BMC Med Inform Decis Mak. 2025;25:402.
   PubMed    
   Abstract available
   
   

7. LIU H, Lu JW, Wu CH, Ho YJ, et al
   Dynamic Immunomodulation by Hydrogen Capsule Therapy in SLE-associated Pulmonary Arterial Hypertension: A Case Report.
   In Vivo. 2025;39:3656-3664.
   PubMed    
   Abstract available
   
   

8. LIU A, Wang H, Xi L, Du J, et al
   Causal Effect of Pulmonary Hypertension on Brain Structure: A Mendelian Randomization Study Combined With Brain Magnetic Resonance Imaging.
   Cureus. 2025;17:e95493.
   PubMed    
   Abstract available
   
   

9. GUENTHER A, Tello S, Schoppe MC, Pons-Kuehnemann J, et al
   Pulmonary Hypertension Drives Prognosis in Idiopathic Pulmonary Fibrosis: Insights from the European IPF Registry.
   J Clin Med. 2025;14:7352.
   PubMed    
   Abstract available
   
   

10. CHOJNACKA K, Singh Y, Gahlaut S, Blaz W, et al
    Persistent Pulmonary Hypertension of the Newborn: A Pragmatic Review of Pathophysiology, Diagnosis, and Advances in Management.
    Biomedicines. 2025;13:2332.
    PubMed    
    Abstract available
    
    

11. XIAODONG Z, Min W, Jinsong H, Yuemei L, et al
    Prolonged intra-aortic balloon pump support successfully reversed severe pulmonary hypertension prior to heart transplantation.
    J Cardiothorac Surg. 2025;20:402.
    PubMed    
    Abstract available
    
    

12. JAIN S, Kaur A, Qadeer A, Ghosh V, et al
    Leveraging Artificial Intelligence for the Diagnosis of Systemic Sclerosis Associated Pulmonary Arterial Hypertension: Opportunities, Challenges, and Future Perspectives.
    Adv Respir Med. 2025;93:47.
    PubMed    
    Abstract available
    
    

13. FISCUS G, Dagher C, O'Sullivan D, Carollo B, et al
    Development of a Tool to Assess the Severity of Pulmonary Hypertension in Patients with Interstitial Lung Disease: A Guide to Assist Therapeutic Choices.
    Adv Respir Med. 2025;93:41.
    PubMed    
    Abstract available
    
    

14. GUAN Y, Wen X, Zhang X, Xu Z, et al
    Novel Pulmonary Manifestations in Pediatric Late-Onset Congenital Central Hypoventilation Syndrome: A Case Series of PHOX2B-Associated Pulmonary Hypertension and Pulmonary Alveolar Hemorrhage.
    Pediatr Pulmonol. 2025;60:e71347.
    PubMed    
    
    
    

15. KEMPTON H, Olsen N, Kearney K, Hayward CS, et al
    Empiric Pulmonary Arterial Compliance Reflects the Resistance-Compliance Relationship and Predicts Mortality in Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70184.
    PubMed    
    Abstract available
    
    

16. LU J, Zinzuwadia A, Sullivan J, Perez-Lopez P, et al
    Echocardiographic Evaluation of Pulmonary Hypertension: A Contemporary Review of the American Society of Echocardiography (ASE) Guidelines and Emerging Modalities.
    Curr Cardiol Rep. 2025;27:154.
    PubMed    
    Abstract available
    
    

17. MANZI G, Badagliacca R, D'Alto M, Ghio S, et al
    [Survey on pulmonary arterial hypertension: a picture of the Italian reality].
    G Ital Cardiol (Rome). 2025;26:833-839.
    PubMed    
    Abstract available
    
    

18. KAMIGAICHI A, Tsutani Y, Tsuchiya A, Utsunomiya H, et al
    Lobectomy Induces Exercise-Induced Pulmonary Hypertension and Effort Intolerance Compared With Sublobar Resection.
    JTO Clin Res Rep. 2025;6:100903.
    PubMed    
    Abstract available
    
    

19. MWIZERWA L, Joye R, Cousin VL, Malaspinas I, et al
    Two case reports of idiopathic prenatal closure of the ductus arteriosus complicated at birth by severe pulmonary hypertension successfully treated without intubation.
    Transl Pediatr. 2025;14:2374-2380.
    PubMed    
    Abstract available
    
    

20. KOSANOVIC D
    High Altitude-Induced Pulmonary Hypertension: Our Scientific Journey to Prove Cold Exposure Is Also an Important Cause.
    Pulm Circ. 2025;15:e70186.
    PubMed    
    
    
    

21. ANNALISA C, Gianmarco S
    Reply To: "Pulmonary Artery Dilatation in Different Causes of Pulmonary Hypertension".
    Pulm Circ. 2025;15:e70175.
    PubMed    
    
    
    

22. BUTROUS G
    Early Development of Sildenafil for Pulmonary Hypertension: A Retrospective Account.
    Pulm Circ. 2025;15:e70188.
    PubMed    
    
    
    

23. CHERNYAEV AL
    Northern Pulmonary Hypertension: Personal Experience and Brief History.
    Pulm Circ. 2025;15:e70190.
    PubMed    
    
    
    

24. KAMENY R, Van Wormer S, Varghese NP
    A Joint Perspective on End-of-Life Care in Pediatric Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70181.
    PubMed    
    
    
    

25. ZHENG W, Li T, Wei J, Yan Y, et al
    Retraction to: Edaravone alleviates lung damage in mice with hypoxic pulmonary hypertension by increasing nitric oxide synthase 3 expression.
    Korean J Physiol Pharmacol. 2025;29:779.
    PubMed    
    
    
    

26. WAKISAKA Y, Inai K, Harada G, Asagai S, et al
    Persistence of pulmonary hypertension in patients with ventricular septal defect after intracardiac repair: insights from a long-term follow-up study.
    Cardiol Young. 2025 Oct 27:1-5. doi: 10.1017/S1047951125110159.
    PubMed    
    Abstract available
    
    

27. ZHOU Y, Xu L, Ou A, Gan S, et al
    Identification of potential core genes in idiopathic pulmonary arterial hypertension: An observational study highlighting the role of VEGFA.
    Medicine (Baltimore). 2025;104:e45398.
    PubMed    
    Abstract available
    
    

28. LEHTINEN ML, Ropponen J, Kesavuori R, Wilkman E, et al
    Bridging to a delayed pulmonary endarterectomy in massive acute-on-chronic pulmonary thromboembolism: a case report.
    J Cardiothorac Surg. 2025;20:391.
    PubMed    
    Abstract available
    
    

29. WATSON H, Patel B, Caccamo M
    Pulmonary Hypertension in Left Heart Disease and Chronic Right Ventricular Failure.
    Med Clin North Am. 2025;109:1345-1364.
    PubMed    
    Abstract available
    
    

30. DENG X, Liu Y, Liang Y, Hu C, et al
    The HIF1alpha-PUM1-KCNK3 axis drives pulmonary hypertension by destabilizing KCNK3 mRNA in pulmonary artery smooth muscle cells.
    Biochim Biophys Acta Mol Basis Dis. 2025;1872:168092.
    PubMed    
    Abstract available
    
    

31. MCKENNA AM, Pradhan NM, Farber HW, Hon SM, et al
    Management of Pulmonary Hypertension in Pregnancy.
    Curr Heart Fail Rep. 2025;22:30.
    PubMed    
    Abstract available
    
    

32. PROHASKA CC, Yaqoob M, Reddy R, Samant M, et al
    Evaluation and Management of Sepsis in Pulmonary Hypertension.
    J Intensive Care Med. 2025 Oct 23:8850666251388409.
    PubMed    
    Abstract available
    
    

33. HU S, Tan JS, Zhu S, Hua L, et al
    Polygenic risk score and clinical factors predict incident idiopathic pulmonary arterial hypertension.
    Respir Med. 2025;248:108404.
    PubMed    
    Abstract available
    
    

34. LIU Z, Fu Q, Shao Y, Cao J, et al
    Triangulation evidence for the causal effect of monocytes on pulmonary artery hypertension: a Mendelian randomization study and results from NHANES.
    Respir Med. 2025;248:108388.
    PubMed    
    Abstract available
    
    

35. REN Y, Gan C
    Atypical presentation of ALCAPA in a young boy: a case report.
    Cardiol Young. 2025;35:2187-2189.
    PubMed    
    Abstract available
    
    

36. YU W, Liu M, Qin W, Liu J, et al
    Artificial Intelligence Chest CT Imaging for the Diagnosis of Tuberculosis-Destroyed Lung with PH.
    Respir Med. 2025 Sep 24:108377. doi: 10.1016/j.rmed.2025.108377.
    PubMed    
    Abstract available
    
    

37. MERC P, Demi?r R, Zeren M, Si?nan UY, et al
    Effects of kettlebell exercise training on functional capacity and metabolic costs of activities of daily living in patients with pulmonary arterial hypertension: A randomized controlled trial.
    Respir Med. 2025;248:108371.
    PubMed    
    Abstract available
    
    

38. LEI C, Su S, Yang Z, Huayu M, et al
    Pharmacodynamic substances and molecular mechanisms of Tsantan Sumtang alleviating hypoxic pulmonary vascular remodeling.
    J Ethnopharmacol. 2026;355.
    PubMed    
    Abstract available
    
    

39. FRAZZETTO F, Piccinelli E, Pilati M, Rebonato M, et al
    Use of atrial flow regulator device in children and patients with CHD: a literature review.
    Cardiol Young. 2025;35:1975-1981.
    PubMed    
    Abstract available
    
    

40. SAHAY S, Palevsky H, El-Kersh K, Restrepo-Jaramillo R, et al
    BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension.
    Respir Med. 2025;248:108318.
    PubMed    
    Abstract available
    
    

41. COBER ND, McCourt E, Godoy RS, Deng Y, et al
    Mapping disease-specific vascular cell populations responsible for obliterative arterial remodelling during the development of pulmonary arterial hypertension.
    Cardiovasc Res. 2025;121:2095-2112.
    PubMed    
    Abstract available
    
    

42. SUCHANEK V, Jakubicek R, Hrdlicka J, Novak M, et al
    Fully automated Bayesian analysis for quantifying the extent and distribution of pulmonary perfusion changes on CT pulmonary angiography in CTEPH.
    Eur Radiol. 2025;35:6996-7003.
    PubMed    
    Abstract available
    
    

43. JING S, Qian J, Ying H, Mao P, et al
    Activin A-Activated ALK4 Induces Pathogenic Th17-Involved Endothelial-Mesenchymal Transition in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
    Arthritis Rheumatol. 2025;77:1533-1547.
    PubMed    
    Abstract available
    
    

44. KUMARI J, Advani M, Purohit G
    Correlation of spirometry findings and post-six-minute walk test oxygen desaturation in chronic simple silicosis patients with age, duration of silica exposure, smoking pack years, occupation and mean pulmonary artery pressure.
    Monaldi Arch Chest Dis. 2025;95.
    PubMed    
    Abstract available
    
    

45. EROL C
    Consensus Report on Pulmonary Hypertension, Gut Microbiota, Postural Orthostatic Tachycardia Syndrome....
    Anatol J Cardiol. 2025;29:598.
    PubMed    
    
    
    

46. WAN CY, Liu YX, Gong SG, Zhao QH, et al
    Non-invasive PECS model for detection of combined post-capillary pulmonary hypertension.
    Front Med (Lausanne). 2025;12:1660387.
    PubMed    
    Abstract available
    
    

47. MOCHIZUKI R, Miyazaki R, Nakatani S, Takai T, et al
    Pulmonary Tumor Thrombotic Microangiopathy Secondary to Extramammary Paget's Disease: An Autopsy Case Report.
    J Dermatol. 2025;52:1727-1731.
    PubMed    
    Abstract available
    
    

48. PAN YS, Xu GR, Qu NN, Qin YB, et al
    Exploration of upstream and downstream mechanisms of the TAGLN2 gene in pulmonary arterial hypertension.
    Medicine (Baltimore). 2025;104:e45295.
    PubMed    
    Abstract available
    
    

49. EILON E, Lishinsky-Fischer N, Levy J
    Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study.
    Eye (Lond). 2025 Nov 4. doi: 10.1038/s41433-025-04093.
    PubMed    
    Abstract available
    
    

50. WANG D, Hu S, Cao J, Fan H, et al
    Establishment of a neonatal rat model of sequential hyperoxic hypoxia to recapitulate clinical progression of bronchopulmonary dysplasia-associated pulmonary hypertension.
    Intensive Care Med Exp. 2025;13:112.
    PubMed    
    Abstract available
    
    

51. BAI Y, Jiang Y, Zhou Y, Xia Y, et al
    The Role of Ferroptosis in the Pathogenesis of Pulmonary Hypertension and Its Therapeutic Potential.
    Eur J Pharmacol. 2025 Nov 1:178316. doi: 10.1016/j.ejphar.2025.178316.
    PubMed    
    Abstract available
    
    

52. QI Y, Liu J, Cui X, Wang Y, et al
    The Diagnostic Value of Transthoracic Echocardiography Parameters Under the New Diagnostic Criteria for Pulmonary Hypertension.
    Can Respir J. 2025;2025:2592204.
    PubMed    
    Abstract available
    
    

53. HAN P, Ma R, Xie W, Li H, et al
    The Predictive Value of Quantitative Analysis of SPECT V/Q Imaging for Postoperative Persistent/Recurrent Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy.
    Pulm Circ. 2025;15:e70195.
    PubMed    
    Abstract available
    
    

54. CHOU YH, Lee YN, Wu SH, Su CH, et al
    Deciphering endothelial aldehyde dehydrogenase 2, oxidative stress, and interleukin-6 interactions in pulmonary hypertension: Implications for precision medicine.
    Biochem Pharmacol. 2025 Oct 31:117510. doi: 10.1016/j.bcp.2025.117510.
    PubMed    
    Abstract available
    
    

55. UHLAND C, Gibbs A, Insel M, Kubba S, et al
    Treatment Response and Survival in Methamphetamine-Associated Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2025;14:e042673.
    PubMed    
    Abstract available
    
    

56. LANDY C, De Blasio MJ, Woodman OL, Maffia P, et al
    Resolution of inflammation in pulmonary arterial hypertension, the influence of sex-An IUPHAR immunopharmacology committee review.
    Br J Pharmacol. 2025;182:5706-5733.
    PubMed    
    Abstract available
    
    

57. YU LL, Jiang DS, Wang X, Fang ZM, et al
    Global, Regional, and National Burden of Pulmonary Arterial Hypertension from 1990 to 2021 and Projections to 2040: A Systematic Analysis of Incidence, Mortality, and Disability-Adjusted Life Years.
    Curr Med Sci. 2025;45:1068-1078.
    PubMed    
    Abstract available
    
    

58. OSGUERITCHIAN R, Jani VP, Mombeini H, Gami A, et al
    Refining Risk Prediction in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    J Am Soc Echocardiogr. 2025;38:1064-1074.
    PubMed    
    Abstract available
    
    

59. VILELA APO, Deffert F, Tonin FS, Pontarolo R, et al
    Overview of Systematic Reviews on Treatments for Pulmonary Arterial Hypertension: Assessing Methodological Quality and Mapping Evidence Gaps.
    Am J Cardiovasc Drugs. 2025;25:779-802.
    PubMed    
    Abstract available
    
    

60. BENJAMIN N, Resag C, Xanthouli P, Harutyunova S, et al
    Fluid Restriction in Patients with Pulmonary Arterial Hypertension and Right Heart Failure.
    Respiration. 2025;104:800-813.
    PubMed    
    Abstract available
    
    

61. DURRINGTON C, Battersby C, Holt L, Fairman A, et al
    NT-proBNP and BNP Testing in Pulmonary Arterial Hypertension: Point-of-Care and Remote Monitoring.
    Respirology. 2025;30:1094-1103.
    PubMed    
    Abstract available
    
    

62. MALI RMA, Ninaber MK, van Mens TE, Konstantinides SV, et al
    Key elements of follow-up care after acute pulmonary embolism focusing on long-term sequelae: a Delphi study among European experts.
    Eur Heart J Qual Care Clin Outcomes. 2025;11:1137-1143.
    PubMed    
    Abstract available
    
    

63. SIUBA MT, Abushamma A, Qureshi A, Ivary S, et al
    Impact of medical therapy on liver transplant eligibility in patients with portopulmonary hypertension: a systematic review.
    Minerva Gastroenterol (Torino). 2025;71:289-294.
    PubMed    
    Abstract available
    
    

64. LIU K, Zeng Y, Wang H, Yang H, et al
    Global, regional, and national burden of pulmonary arterial hypertension and related heart failure from 1990 to 2021, with predictions to 2050: insights from the global burden of disease study 2021.
    Eur Heart J Qual Care Clin Outcomes. 2025;11:969-980.
    PubMed    
    Abstract available
    
    

65. LI S, Zhang J, Wang X, Wang X, et al
    Super-Enhancer Target Gene CBP/p300-Interacting Transactivator With Glu/Asp-Rich C-Terminal Domain, 2 Cooperates With Transcription Factor Forkhead Box J3 to Inhibit Pulmonary Vascular Remodeling.
    Cell Prolif. 2025;58:e13817.
    PubMed    
    Abstract available
    
    

66. CHAI S, Xu H, Xu G, Cai C, et al
    ORENITRAM's decadal journey: unveiling safety profiles and adverse event through a real-world pharmacovigilance study of FAERS events.
    Expert Opin Drug Saf. 2025;24:1265-1280.
    PubMed    
    Abstract available
    
    

67. LANDI I, Alharbil S, Alfehaid A, Aldosari S, et al
    Clinical and echocardiographic predictors of outcome in liver transplant patients.
    Monaldi Arch Chest Dis. 2025;95.
    PubMed    
    Abstract available
    
    

68. BRUNELLE K, Dempsey N, Marks B, Paulin B, et al
    The Pulmonary Hypertension Association of Canada: Patient Voices From Bench to Bedside and Beyond.
    J Card Fail. 2025;31:1789-1791.
    PubMed    
    Abstract available
    
    

69. KAMENY RJ, Hopper RK
    Cardiology Overview of Pulmonary Hypertension Management in the Neonatal Intensive Care Unit.
    Clin Perinatol. 2025;52:633-653.
    PubMed    
    Abstract available
    
    

70. ZHENG X, Li X, Shen Z, Guo P, et al
    Inhalation formulations targeting nitric oxide pathways for pulmonary hypertension therapy: current advances and future directions.
    Int J Pharm. 2025 Nov 11:126384. doi: 10.1016/j.ijpharm.2025.126384.
    PubMed    
    Abstract available
    
    

71. ZHANG B, Li P, Huang L, Wang C, et al
    LINC03047 promotes mitophagy by recruiting hnRNPF to enhance CTGF mRNA stability in hypoxic pulmonary hypertension.
    Free Radic Biol Med. 2025 Nov 11:S0891-5849(25)01352.
    PubMed    
    Abstract available
    
    

72. MARTINEZ MANZANO JM, Kosak Lopez E, Geller A, Wattanachayakul P, et al
    Association of borderline pulmonary artery wedge pressure with major cardiovascular events in patients with pulmonary hypertension and chronic kidney disease.
    Heart Lung. 2025;76:26-31.
    PubMed    
    Abstract available
    
    

73. YOU Z, Huang Q, Zeng L, Tian X, et al
    Rab26 promotes hypoxia-induced hyperproliferation of PASMCs by modulating the AT1R-STAT3-YAP axis.
    Cell Mol Life Sci. 2025;82:396.
    PubMed    
    Abstract available
    
    

74. ZHAO H, Chakinala MM, Fallon MB, Lin SM, et al
    Endothelial Heterogeneity in Pulmonary Hypertension.
    Arterioscler Thromb Vasc Biol. 2025 Nov 13. doi: 10.1161/ATVBAHA.125.322482.
    PubMed    
    Abstract available
    
    

75. OKAMOTO A, Yamaguchi T, Yamazaki T, Ehara S, et al
    Magnetic resonance direct thrombus imaging to distinguish acute pulmonary embolism from chronic thromboembolic pulmonary hypertension: a case report.
    Eur Heart J Case Rep. 2025;9:ytaf555.
    PubMed    
    Abstract available
    
    

76. MORIARTY N, Vadiveloo TDV, Osman F, Benson R, et al
    Raynaud's Phenomenon and Pericardial Effusion Requiring Management with A Pericardial Window as the only Manifestations of Systemic Sclerosis without Scleroderma for over 10 Years, after which Pulmonary Hypertension Developed.
    Eur J Case Rep Intern Med. 2025;12:005866.
    PubMed    
    Abstract available
    
    

77. WANG L, Fischmeister R, Manoury B
    Cyclic Nucleotide Phosphodiesterase Families as Targets to Treat Pulmonary Arterial Hypertension: Beyond PDE5 Inhibitors?
    Cells. 2025;14:1670.
    PubMed    
    Abstract available
    
    

78. BARTOSZEWSKA E, Chrapkowska A, Zielinska O, Mordalska M, et al
    Atrial Septal Defects: From Embryology to Pediatric Pulmonary Hypertension.
    J Clin Med. 2025;14:7698.
    PubMed    
    Abstract available
    
    

79. MADONNA R, Tocci G, Biondi F, Cipollini V, et al
    Chronic Thromboembolic Pulmonary Disease: Right Ventricular Function and Pulmonary Hemodynamics in a 4-Year Follow-Up.
    Int J Mol Sci. 2025;26:10617.
    PubMed    
    Abstract available
    
    

80. RADA-PASCUAL KM, Zuniga-Munoz AM, Alvarez-Alvarez YQ, Del Valle-Mondragon L, et al
    Fenofibrate as a Modulator of the Renin-Angiotensin System in Su/Hx-Induced Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2025;26:10251.
    PubMed    
    Abstract available
    
    

81. ZHANG H, Yang B, Liu B, Luo Q, et al
    Long-term outcomes and prognostic predictors in patients with fibrosing mediastinitis associated pulmonary hypertension: a multicenter cohort study.
    Orphanet J Rare Dis. 2025;20:576.
    PubMed    
    Abstract available
    
    

82. CUOMO A, Normand C, Thuillet R, Jaffrezic T, et al
    The activin pathway in chronic thromboembolic pulmonary hypertension: a potential biomarker for residual pulmonary hypertension after endarterectomy.
    ERJ Open Res. 2025;11:01302-2024.
    PubMed    
    Abstract available
    
    

83. LIM L, Hansen D, Fairley J, Tabesh M, et al
    Impact of Comorbidities on Treatments and Outcomes of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    Can Respir J. 2025;2025:5021789.
    PubMed    
    Abstract available
    
    

84. CASTILLO-RODRIGUEZ C, Aronow WS, Frishman WH, Pineda AB, et al
    From Pathways to Patients: Contemporary Approaches to Pulmonary Hypertension.
    Cardiol Rev. 2025 Nov 12. doi: 10.1097/CRD.0000000000001121.
    PubMed    
    Abstract available
    
    

85. YAN LN, Liu M, Zhao L, Chen WH, et al
    [A case of diffuse cystic lung disease with severe pulmonary hypertension in a reproductive-aged female].
    Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:1056-1059.
    PubMed    
    Abstract available
    
    

86. ZEDER K, Brown CH, Santi A, Cvirn L, et al
    The prevalence of pulmonary hypertension associated with left heart disease - a systematic review and meta-analysis.
    Cardiovasc Res. 2025 Nov 11:cvaf226. doi: 10.1093.
    PubMed    
    Abstract available
    
    

87. TANI R, Iwaya T, Nakanishi N, Yukawa A, et al
    Effects of Nitric Oxide on Hemodynamics After Transcatheter Mitral Valve Repair Complicated by Pulmonary Hypertension?- A Study Protocol.
    Circ Rep. 2025;7:1141-1145.
    PubMed    
    Abstract available
    
    

88. PICCARI L, Rodriguez-Chiaradia DA, Garcia-Ortega A
    Pulmonary Hypertension Associated With Lung Disease: Is a Jar Half Full or Half Empty?
    Open Respir Arch. 2025;8:100499.
    PubMed    
    
    
    

89. ZHANG W, Zhang M, Sha Z, Yao Y, et al
    TRIB2 Promotes Pulmonary Artery Smooth Muscle Cell Proliferation through SERCA2 Ubiquitination in Pulmonary Hypertension.
    Free Radic Biol Med. 2025 Nov 8:S0891-5849(25)01344.
    PubMed    
    Abstract available
    
    

90. WILLER AS, Ruffenach G, Masson B, El Jekmek K, et al
    Combination of Orai1 inhibitor CM5480 with specific therapy mitigates pulmonary hypertension and its cardiac dysfunction.
    JCI Insight. 2025;10:e191780.
    PubMed    
    Abstract available
    
    

91. SAHAY S, Sisk M, Nelsen A, Wu B, et al
    Real-world use of initial combination treatment in the management of pulmonary arterial hypertension.
    Ther Adv Respir Dis. 2025;19:17534666251390070.
    PubMed    
    Abstract available
    
    

92. BURGER CD, Wu J, O'Brien G, Makulova N, et al
    Incremental Burden of Pulmonary Hypertension Among Patients With Interstitial Lung Disease in the Real-World Setting.
    Pulm Circ. 2025;15:e70201.
    PubMed    
    Abstract available
    
    

93. FENG T, Yuan W, Tie H, Zhang F, et al
    The value of echocardiographic left ventricular rotational body volume analysis in the assessment of patients with pulmonary hypertension.
    Quant Imaging Med Surg. 2025;15:10920-10935.
    PubMed    
    Abstract available
    
    

94. KACAR P, Prokselj K, Ghonim S, Semple T, et al
    Advances in the imaging of pulmonary hypertension.
    Int J Cardiol Congenit Heart Dis. 2025;22:100619.
    PubMed    
    Abstract available
    
    

95. OGO T, Shinke T, Inami T, Ikeda N, et al
    Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: A Nationwide Prospective Multicenter Registry in Japan (J-BPA).
    Circ Cardiovasc Interv. 2025 Nov 9. doi: 10.1161/CIRCINTERVENTIONS.125.016172.
    PubMed    
    Abstract available
    
    

96. DE OLIVEIRA ECF, Cotta RCF, Rocha ALL
    Outpatient Insertions of the Levonorgestrel-Releasing Intrauterine System in Women with Pulmonary Hypertension: A Case Series.
    Contraception. 2025 Nov 6:111289. doi: 10.1016/j.contraception.2025.111289.
    PubMed    
    Abstract available
    
    

97. MINATSUKI S, Hatano M, Ishii S, Hirose K, et al
    Prospective safety assessment of the acute vasoreactivity test using an inhaled nitric oxide delivery system in pulmonary hypertension.
    Int J Cardiol. 2025 Nov 6:134009. doi: 10.1016/j.ijcard.2025.134009.
    PubMed    
    Abstract available
    
    

98. KHAN A, Naquvi KJ, Gupta PS
    Critical Appraisal of "A Machine Learning-Based Model to Estimate the Risk of Pulmonary Hypertension in Chronic Kidney Disease Patients".
    J Clin Hypertens (Greenwich). 2025;27:e70175.
    PubMed    
    
    
    

99. XIAO Y, Cai Z, Bai M, Wu X, et al
    Harnessing NLRX1: a new frontier in mitigating inflammation in pulmonary hypertension.
    Respir Res. 2025;26:311.
    PubMed    
    Abstract available
    
    

100. SCHWAB ME, Martin E, Si X, Chao SD, et al
     Pectus Excavatum Repair During Lung Transplantation in a 5-Year-Old: A Case Report.
     Interdiscip Cardiovasc Thorac Surg. 2025;40:ivaf263.
     PubMed    
     Abstract available
     
     

101. BOLOTIN T, Subedi S, Dahal S, Walker C, et al
     High Altitude Pulmonary Edema Response to Continuous Airway Positive Pressure: A Randomized Controlled Trial: The HAPER CAPER Trial.
     Acad Emerg Med. 2025;32:1215-1223.
     PubMed    
     Abstract available
     
     

102. HEI B, Zhang A, Yang M, Jiang Y, et al
     Liver Kinase B1 Protects Against Hypoxia-Induced Pulmonary Arterial Endothelial Cell Dysfunction via the AMP-Activated Protein Kinase Pathway.
     Biochem Genet. 2025;63:5593-5607.
     PubMed    
     Abstract available
     
     

103. MUSCH TI, Schulze KM, Poole DC
     Evaluating the evidence for dietary nitrate to impact skeletal muscle blood flow in a rat model of pulmonary hypertension.
     Am J Physiol Regul Integr Comp Physiol. 2025;329:R905-R906.
     PubMed    
     
     
     

104. FIGUEIRA RL, Doktor F, Moheimani N, Lauriti G, et al
     Incidence and risk factors of pulmonary hypertension in neonates with congenital diaphragmatic hernia: a systematic review and meta-analysis.
     Pediatr Surg Int. 2025;42:23.
     PubMed    
     Abstract available
     
     

105. LIANG Z, Li Y, Jia S, Liu Y, et al
     Plasma interferon predicts pulmonary hypertension severity and outcome.
     Front Cardiovasc Med. 2025;12:1634764.
     PubMed    
     Abstract available
     
     

106. KHEIWA A, Saadat V, Chung J, Nageotte S, et al
     Secondary pulmonary hypertension in an adult patient with Ebstein anomaly post-atrial septal defect closure; can it be reversible? A case report.
     Eur Heart J Case Rep. 2025;9:ytaf527.
     PubMed    
     Abstract available
     
     

107. MATAMA H, Asano R, Endo H, Takano R, et al
     Long-term outcome of patients with Eisenmenger syndrome receiving pulmonary arterial hypertension-targeted therapy.
     Open Heart. 2025;12:e003721.
     PubMed    
     Abstract available
     
     

108. YE B, Su D, Huang Y, Liu D, et al
     Interaction of circPcmtd1 with HSP90AB1 mediates phosphorylation of AKT to regulate pulmonary arterial hypertension induced by high pulmonary blood flow in rat.
     Clin Exp Hypertens. 2025;47:2583193.
     PubMed    
     Abstract available
     
     

109. ZHANG S, Tang M, Wu Q, Tan H, et al
     Transcatheter hybrid closure of a large muscular ventricular septal defect with severe pulmonary hypertension using a duct occluder.
     Clin Exp Hypertens. 2025;47:2586068.
     PubMed    
     Abstract available
     
     

110. FAN L, Davo-Jimenez M, Benefield BC, Beydoun N, et al
     Cardiovascular MRI-based Biventricular Perfusion Assessment in Two Patients with Chronic Thromboembolic Pulmonary Hypertension Undergoing Pulmonary Thromboendarterectomy.
     Radiol Cardiothorac Imaging. 2025;7:e250296.
     PubMed    
     Abstract available
     
     

111. WILLEMS L, Camilleri E, Bosmans E, Verhaegen J, et al
     Circulating Pin1 Levels in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Case-Control Study.
     Pulm Circ. 2025;15:e70209.
     PubMed    
     Abstract available
     
     

112. ZIELINSKY P, Henriques P, Van Der Sand P, Saldanha MA, et al
     Fetal Ductal Constriction, Pulmonary Hypertension and Atrial Septum Mobility: A Correlation Study.
     J Ultrasound Med. 2025 Nov 20. doi: 10.1002/jum.70130.
     PubMed    
     Abstract available
     
     

113. LE BOZEC A, Cohen SD, Montani D, Boucly A, et al
     Diuretic adherence in patients with pre-capillary pulmonary hypertension: insights from the PHARE study.
     ERJ Open Res. 2025;11:00110-2025.
     PubMed    
     Abstract available
     
     

114. SHAMS SM, Maldarelli ME, Cassady S, Ramani G, et al
     Combination AI-Machine Learning to Diagnose Pulmonary Hypertension: A Real-World Evidence Cohort Study.
     medRxiv [Preprint]. 2025 Oct 1:2025.09.30.25336749.
     PubMed    
     Abstract available
     
     

115. MIELGO V, Catozzi C, Ricci F, Villetti G, et al
     Caffeine Protects Newborn Rat Lungs Against the Effects of Hyperoxia and Intra-Amniotic Enterotoxin.
     Pediatr Pulmonol. 2025;60:e71395.
     PubMed    
     Abstract available
     
     

116. VENKATESHVARAN A, Lindow T, Jumatate R, Kovacs A, et al
     Prognostic Value of Right Ventricular Global Wasted Work in Precapillary Pulmonary Hypertension: A 3D Echocardiographic Study.
     Echocardiography. 2025;42:e70344.
     PubMed    
     Abstract available
     
     

117. YI W, Minghui Z, Le Z, Yingying W, et al
     Substance P Promotes Pulmonary Hypertension by Inducing Fibulin-2 Methylation to Regulate beta-Catenin.
     Pulm Circ. 2025;15:e70196.
     PubMed    
     Abstract available
     
     

118. ZHAO QH, Zhang R, Liu SF, Luo CJ, et al
     Phenotypic Analysis of Pulmonary Hypertension Associated With Low Diffusion Capacity and Preserved Lung Function.
     Pulm Circ. 2025;15:e70210.
     PubMed    
     Abstract available
     
     

119. KOLAITIS NA, Sahay S, Rosenzweig EB, Brown D, et al
     American Lung Association Pulmonary Hypertension Roundtable: Executive Summary.
     Pulm Circ. 2025;15:e70200.
     PubMed    
     Abstract available
     
     

120. OREN MS, Babata K, Hu J, Kakkilaya V, et al
     Early Oxygenation and Mortality in Infants Treated with Inhaled Nitric Oxide (iNO) for Persistent Pulmonary Hypertension of the Newborn (PPHN).
     J Pediatr Clin Pract. 2025;18:200189.
     PubMed    
     Abstract available
     
     

121. YANG L, Ni Q, He Y, Liu S, et al
     OSA Initiates Histone Lactylation That Drives PDE4B/FUS/AGT Axis to Pulmonary Hypertension.
     Cell Prolif. 2025 Nov 17:e70145. doi: 10.1111/cpr.70145.
     PubMed    
     Abstract available
     
     

122. BELLOUCHE Y, Tromeur C, Le Ven F, Robin P, et al
     Proximal pulmonary artery wall shear stress derived from computational fluid dynamics: A noninvasive biomarker for CTEPH and perfusion mismatch.
     Physiol Rep. 2025;13:e70664.
     PubMed    
     Abstract available
     
     

123. ZHOU J, Hou X, Zheng Z, Quan T, et al
     Chronic nicotine exposure drives dose-dependent pulmonary hypertension and cardiopulmonary remodeling: Preclinical and clinical validation.
     Microvasc Res. 2025 Nov 14:104884. doi: 10.1016/j.mvr.2025.104884.
     PubMed    
     Abstract available
     
     

124. LIU A, Wang J, Xi L, Wang H, et al
     Characteristics of ferritinophagy-related genes in chronic thromboembolic pulmonary hypertension, a study based on bioinformatics with machine learning model.
     Respir Med. 2025 Nov 13:108493. doi: 10.1016/j.rmed.2025.108493.
     PubMed    
     Abstract available
     
     

125. SEDLAR A, Bojarova P, Kolar F, Kren V, et al
     Galectin-3 as a therapeutic target in pulmonary hypertension: Molecular mechanisms, drug development directions, and emerging clinical applications.
     Biomed Pharmacother. 2025;193:118756.
     PubMed    
     Abstract available
     
     

126. SALVI M, Guarino D, Ballerini A, Chietera F, et al
     Severe Precapillary Pulmonary Hypertension Due to Whipple Disease.
     JACC Case Rep. 2025 Nov 15:105939. doi: 10.1016/j.jaccas.2025.105939.
     PubMed    
     Abstract available
     
     

127. NIU Y, Tian J, Provencher S, Bonnet S, et al
     Protein biomarkers in pulmonary arterial hypertension: advances, clinical relevance, and translational challenges.
     J Transl Med. 2025;23:1288.
     PubMed    
     Abstract available
     
     

128. GONZALEZ-ARRIBAS G, Freire-Gonzalez M, Silva-Fernandez L, de Toro Santos J, et al
     Application of the DETECT algorithm in a cohort of patients with systemic sclerosis.
     Reumatol Clin (Engl Ed). 2025;21:501970.
     PubMed    
     Abstract available
     
     

129. GIANCASPRO G, Rotondo C, Barile R, Rella V, et al
     Causes of dyspnea in autoimmune rheumatic disorders: beyond interstitial lung disease and pulmonary arterial hypertension.
     Respir Med. 2025;249:108491.
     PubMed    
     Abstract available
     
     

130. WU Y, Liu Y, Shan L, Li X, et al
     HIF1alpha/PRDX1 axis drives pulmonary vascular remodeling through DRP1 DeSUMOylation and mitochondrial fragmentation.
     Biochim Biophys Acta Mol Basis Dis. 2026;1872:168094.
     PubMed    
     Abstract available
     
     

131. PAULING JD, Allanore Y, Buch MH, Cutolo M, et al
     Exploiting a unified vascular framework to predict organ-specific complications and accomplish disease modification in systemic sclerosis.
     Lancet Rheumatol. 2025;7:e895-e906.
     PubMed    
     Abstract available
     
     

132. TAMURA Y, Tamura Y, Takemura R, Taniguchi Y, et al
     Immunosuppressive Therapy for Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases: Insights from Japanese Registry.
     Adv Ther. 2025;42:6103-6117.
     PubMed    
     Abstract available
     
     

133. LUCERO MJ, Lisk C, Swindle D, Cendali F, et al
     Combined haptoglobin and hemopexin therapy for the treatment of cardiopulmonary dysfunction in sickle cell disease.
     Biomed Pharmacother. 2025;192:118595.
     PubMed    
     Abstract available
     
     

134. BADAGLIACCA R, Tello K, D'Alto M, Ghio S, et al
     TAPSE/sPAP Ratio to Improve Risk Assessment in Pulmonary Arterial Hypertension.
     Circ Heart Fail. 2025 Sep 17:e012518. doi: 10.1161/CIRCHEARTFAILURE.124.012518.
     PubMed    
     Abstract available
     
     

135. FUKUSHIMA M, Ueno Y, Ayano Y, Takahashi K, et al
     Sustained effectiveness of balloon-occluded retrograde transvenous obliteration for portopulmonary hypertension after liver transplantation: a 5-year follow-up case report.
     Clin J Gastroenterol. 2025;18:1137-1143.
     PubMed    
     Abstract available
     
     

136. ESSAFRI I, Ichimura K, Ivy D, Stenmark KR, et al
     The effect of microvascular remodeling on fluid dynamics in the pressure-overloaded right ventricle.
     Am J Physiol Heart Circ Physiol. 2025;329:H1379-H1390.
     PubMed    
     Abstract available
     
     

137. KOHLI A, DuBrock HM, Boland JM, Kennedy CC, et al
     A Tale of Two Pathologies: Unraveling CTEPH and PVOD in Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2025 Oct 24. doi: 10.1164/rccm.202505-1140.
     PubMed    
     
     
     

138. SAVALE L, d'Humieres T, Boucly A, Habibi A, et al
     Cardiopulmonary Hemodynamic Determinants of Long-Term Survival in Sickle Cell Disease: Insights from the ETENDARD Study.
     Am J Respir Crit Care Med. 2025;211:2096-2104.
     PubMed    
     Abstract available
     
     

139. ZEDER K, Kundu S, Siew ED, Annis JS, et al
     Longitudinal Pulmonary Arterial Pressure Trajectories and Clinical Outcome in Kidney Transplantation Patients.
     Chest. 2025;168:1200-1214.
     PubMed    
     Abstract available
     
     

140. MARTIN DE MIGUEL I, Lopez-Guarch CJ, Segura de La Cal T, Nieto SH, et al
     Chronic thromboembolic pulmonary disease with exercise pulmonary hypertension - A non-invasive model to predict exercise hemodynamics.
     Chest. 2025 Nov 12:S0012-3692(25)05680-6. doi: 10.1016/j.chest.2025.
     PubMed    
     Abstract available
     
     

141. JEVNIKAR M, Brenot P, Kularatne M, Rodiere A, et al
     Chronic thromboembolic pulmonary hypertension associated with venous thoracic outlet syndrome: a retrospective case series.
     Eur Respir J. 2025 Nov 6:2501610. doi: 10.1183/13993003.01610-2025.
     PubMed    
     
     
     

142. OSORIO J, Tura-Ceide O, Pavia J, Vollmer I, et al
     Increased lung [(18)F]-FDG uptake in chronic thromboembolic pulmonary hypertension with distal involvement.
     Eur Respir J. 2025 Nov 6:2500130. doi: 10.1183/13993003.00130-2025.
     PubMed    
     
     
     

143. ZHANG H, Ren J, He Y, Zhao K, et al
     GPX4: A Key Regulator of Mitochondrial Function and Glycolysis in Pulmonary Artery Smooth Muscle Cells.
     J Cardiovasc Pharmacol. 2025;86:489-497.
     PubMed    
     Abstract available
     
     

144. ABREU P, Moon R, Mendelson JB, Markowski T, et al
     Proteomic and metabolomic profiling nominates druggable targets and biomarkers for pulmonary arterial hypertension-associated myopathy and exercise intolerance in male monocrotaline rats.
     J Heart Lung Transplant. 2025;44:1798-1808.
     PubMed    
     Abstract available
     
     

145. HJALMARSSON C, Thakur T, Weiss T, Bjorklund E, et al
     Risk assessment models and survival in pulmonary arterial hypertension: A SPAHR analysis.
     J Heart Lung Transplant. 2025;44:1787-1797.
     PubMed    
     Abstract available
     
     

146. SUETOMI T, Shimokawahara H, Kuronuma K, Sugiyama Y, et al
     Pulmonary Artery Fresh Floating Thrombus in Patients with Chronic Thromboembolic Pulmonary Hypertension on Low-Dose Direct Oral Anticoagulants: A Single-Center Angiographic Observational Study.
     J Heart Lung Transplant. 2025 Nov 14:S1053-2498(25)02368.
     PubMed    
     Abstract available
     
     

147. GARCIA-GOZALO M, Jain A, Weisz DE, Jasani B, et al
     Can N-terminal pro-brain natriuretic peptide accurately diagnose chronic pulmonary hypertension among extremely low gestational age neonates: A Retrospective Cohort Study.
     J Perinatol. 2025 Nov 13. doi: 10.1038/s41372-025-02462.
     PubMed    
     Abstract available
     
     

148. PLACIDO R, Baptista B
     Ortner's Syndrome in Pulmonary Hypertension.
     N Engl J Med. 2025;393:e35.
     PubMed    
     
     
     

149. BERGOT E, Fertin M, Dewavrin MG, Prevot G, et al
     Start up: A French program to support patients with pulmonary arterial hypertension during the adjustment of prostanoids to the individualized optimal dose.
     PLoS One. 2025;20:e0331008.
     PubMed    
     Abstract available